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Abstract
Background: Breathlessness is one of the core symptoms, particularly persistent and frequent, towards the end of
life. There is no evidence of how the experience of breathlessness differs across conditions. This paper compares
the experience of breathlessness in cancer, COPD, heart failure and MND, four conditions sharing heavy symptom
burdens, poor prognoses, high breathlessness rates and palliative care needs.
Methods: For this qualitative study a purposive sample of 48 patients was included with a diagnosis of cancer (10),
COPD (18), heart failure (10) or MND (10) and experiencing daily problems of breathlessness. Patients were
recruited from the respective clinics at the hospital; specialist nurses’ ward rounds and consultations, and “Breathe
Easy” service users meetings in the community. Data were collected through semi-structured, in-depth interviews
and participant observation. Breathlessness was compared according to six components derived from explanatory
models and symptom schemata, first within groups and then across groups. Frequency counts were conducted to
check the qualitative findings.
Results: All conditions shared the disabling effects of breathlessness. However there were differences between the
four conditions, in the specific constraints of the illness and patients’ experiences with the health care context and
social environment. In cancer, breathlessness signalled the (possible) presence of cancer, and functioned as a
reminder of patients’ mortality despite the hopes they put in surgery, therapies and new drugs. For COPD patients,
breathlessness was perceived as a self-inflicted symptom. Its insidious nature and response from services
disaffirmed their experience and gradually led to greater disability in the course of illness. Patients with heart failure
perceived breathlessness as a contributing factor to the negative effects of other symptoms. In MND breathlessness
meant that the illness was a dangerous threat to patients’ lives. COPD and heart failure had similar experiences.
Conclusion: Integrated palliative care is needed, that makes use of all appropriate therapeutic options,
collaborative efforts from health, social care professionals, patients and caregivers, and therapies that acknowledge
the dynamic interrelation of the body, mind and spirit.
Background
A recent comparison of symptom prevalence among
people with five advanced, life-limiting diseases found
that breathlessness is one of the core symptoms which
are particularly persistent and frequent towards the end
of life [1]. Breathlessness is a symptom which affects
patients with many conditions: it is a common problem
in advanced cancer with a prevalence of up to 70%, 95%
in chronic obstructive pulmonary disease (COPD), 88%
in cardiac failure and 85% in motor neuron disease
(MND) [1,2].
Breathlessness is defined by the American Thoracic
Society as “as u b j e c t i v ee x p e r i e n c eo fb r e a t h i n gd i s c o m -
fort that consists of qualitatively distinct sensations that
vary in intensity" [3]. This definition appreciates the com-
plexity of this symptom coming from interactions among
multiple physiological, psychological, social and environ-
mental factors, modulating both the quality and the
intensity of the person’s perception of breathlessness [4],
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vioural responses [3].
Progress in management of breathlessness has been
slow. Work has focused on its clinical management and
less is known about its experience [5]. Qualitative stu-
dies can provide in-depth information about effects of
breathlessness on patients’ and carers’ lives [6]. Patients
construct explanatory models (EM) to make sense of
specific symptom episodes in the direct context of their
illness and the broader context of the patient’s life [7,8].
It is essential to take these into account, in relation to
breathlessness which is difficult to manage and therefore
often underestimated, insufficiently elicited or reported,
and undertreated [9-11].
Even when managed by specialists, breathlessness is
difficult to control [12]. It is therefore worthwhile to
explore breathlessness outside of specialist knowledge
and look whether its experiences are similar or different
across conditions. What are the differences caused by, if
there are any? Are there transferable strategies to cope
with this symptom in approaches developed in other
conditions?
We aimed to explore and compare the lived experience
of breathlessness for patients with four conditions -COPD,
heart failure, cancer and MND- all with heavy symptom
burden, poor prognoses, high breathlessness rates and pal-
liative care needs. COPD, heart failure and cancer are the
most common chronic diseases worldwide and their pre-
valence is rising [13]. MND represents the experience of
neurological disorders which need complex and intensive
care from a range of health and social services [14].
Chronic illness imposes costs at all levels of society [15].
Addressing a distressing symptom as breathlessness may
help considerably in the containment of the economic
burden of such conditions, and improve quality of life.
Methods
Design
Qualitative study of face-to-face cross-sectional inter-
views and participant observation with patients with one
of four conditions.
Context and sample
Data were collected in a qualitative study exploring the
experiences of breathlessness. The study took place in a
large teaching hospital and in the community, in
London.
We used a purposive sample of patients with a diagno-
sis of cancer, COPD, heart failure and MND and experi-
encing daily problems of breathlessness. Patients were
recruited over eight months from respiratory, cancer,
heart failure, MND clinics at the hospital; specialist
nurses’ ward rounds and consultations, “Breathe Easy”
service users meetings, and the community. Patients
were prioritised who were in the advanced stages of ill-
ness (moderate to severe breathlessness in COPD, people
with New York Heart Association stage 3 or 4 disease in
heart failure, patients with palliative care needs in cancer
and MND). We asked patients to participate who were
able and willing to communicate their experiences in a
lengthy interview, in order to maximise understanding of
how they experience breathlessness and care towards this
symptom.
Data collection
Consenting patients were interviewed at home, except for
two patients, who preferred to be interviewed in the
researcher’s office. The interviews were in-depth and
semi-structured; a topic guide was used as an aide-mem-
oir, following a number of broad themes, ensuring that
all the relevant topics were covered. All were tape
recorded and transcribed verbatim, except two, which
could not be recorded for technical reasons. During
these, detailed notes were taken and written up immedi-
ately after the interview. Discussions with participants
which were not recorded, e.g. what they told the
researcher after the interview, when the tape recorder
had already been switched off, and the participant took
up one of the topics again from the interview, were also
written down afterwards.
The researcher was a participant observer in consulta-
tions of health professionals and in Breathe Easy meet-
ings. Field notes were kept of non-verbal aspects (e.g.
body language or tone of voice) and in situations in
which it was inappropriate to tape record, which pro-
vided additional data to the more theoretical insights
being generated. Data were collected until a point of
saturation was reached, i.e. when no more new informa-
tion emerged from the data, and no additional insights
were generated.
Analysis
We used the concept of EM [7] and Symptom
Schema [16] as the framework for the analysis of the
patients’ experiences of breathlessness. We constructed a
coding scheme relevant for the symptom of breathless-
ness by combining components of these models that
were: label, cause of illness, nature of breathlessness, time
line, treatment/coping (separately for breathlessness and
for illness), consequences of breathlessness in the context
of illness. The texts of transcribed interviews and discus-
sions were read and coded in NVivo. Initial detailed cod-
ing allowed the identification of the range of patients’
perceptions or experiences within these components and
the discovery of unexpected dimensions. Through a pro-
cess of constantly integrating categories and their proper-
ties, or constant comparison, the findings became
relevant at a more abstract level. In parallel, meaningful
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ing scheme were categorised in an ExceL spread sheet, to
enhance the visibility of similarities and differences
between cases. The links between condition and the
more abstract categories generated in the analysis were
checked by frequency counts. These were presented in a
table to show the numerical distribution across the differ-
ent conditions (see Table 1). The analysis was carried out
in several stages. First, we focused on within-group
experiences and perspectives in relation to the
components of EMs. Second, we compared and con-
trasted experiences in different conditions. Our compara-
tive approach was case-based and adopted an interpretive
model which starts from the idea that any behavior, per-
ception, attitude can only be understood within its social
context.
Accuracy of the data was verified in various ways.
First, the data from the interviews were confronted with
data from participant observation in consultations
between health professionals and patients. Frequency
Table 1 Themes in conditions
THEMES in the experience of breathlessness CONDITIONS compared
Themes Sub-themes Cancer COPD HF MND
Nature Manifestation (sudden/surreptitious) 4 12 7 10
Evaluative (worst symptom) 1 11 4 2
Associated feelings (fear) 4 18 2 10
Influence on life (inhibiting) 3 17 9 10
Label No immediate diagnosis 1 18
Diagnosis carrying meaning 10 1 10
Diagnosis not carrying meaning 17
Long search for diagnosis 10
Time line Awareness of diagnosis after test for symptoms 10
Awareness of diagnosis in retrospect 18
Awareness after manifestation of symptoms and confirmed by test 10 2
Step by step awareness 8
Cause Internal 2 7
External 5 18
Both 2 2 3
Not clear 1 10
Coping symptom No advice 9 12 8
PR 1 5 2
Essential breathing aids 10
Coping illness Psychological/spiritual mechanisms 7 4 6 10
Self-management 5
Caution strategies 11 10
Hope in surgery for cure 4 7
Hope in treatment for extending life 5
Lack of coping (suffering) 11 2
Reliance on medication 10
Consequences Family 3 9 3 10
Financial 2 12 2 3
Disability 2 18 10 10
Search for cure 3
Fear of dying/death 3 12 6
Stigma 2 10 3 3
Access to care 12 6
Copers 5
The numbers are representative of how many times something is mentioned throughout the interviews, therefore they may not always add up to the number of
interviewees in each group.
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occurrence matching those found in the interviews. We
also present direct illustrative quotations from the data.
Results
We conducted a total of 48 interviews with patients.
Interviews lasted between 40 and 150 minutes, with a
mean of 65 minutes (see Table 2).
Cancer
The nature of breathlessness
Patients described breathlessness in terms of how it mani-
fested itself and the feelings it evoked. It appeared sud-
denly and it was described as frightening. Those people
who said it was untypical for them to panic said that
breathlessness had this effect on them. Three patients said
that breathlessness had an inhibiting effect, which made
them more cautious in what they undertook, and it made
them worry about the future.
Label
A diagnosis of cancer was preceded by tests, not always
giving an immediate definite result, requiring more tests
to be carried out over a period of time. This was impor-
tant in the case of a diagnosis of cancer as it was loaded
with meaning.
‘I think when they say that word it makes you like ill
anyway don’t ya?’
Timeline
To receive the label ‘cancer’ was described as a shock by
all patients and immediately associated with dying. The
concern about the breathing problems for which they
originally sought professional help, faded in importance
when cancer was suspected. In retrospect, the symptoms
were experienced as announcing cancer. To experience
this first sudden sensation of breathlessness was
described as ‘strange’, ‘a mystery’.
When they received their diagnosis they either
enquired about or were given a prognosis.
‘...and er they said it’s cancer and I asked him straight
I said well: what’s the life expectancy?’
Cause
Most of the patients mentioned an external cause for their
diagnosis (7), exclusively or in combination with an inter-
nal cause. External causes were influences from outside,
such as smoking, a ‘bad pattern of life’, or environmental,
due to unhealthy work places, or stressful experiences.
Internal causes were due to a malfunctioning in the body.
Treatment/coping with breathlessness
Nine out of the 10 patients said they had never received
advice on how to deal with breathlessness. Only one
patient was referred to pulmonary rehabilitation (PR)
where she learned breathing techniques and other stra-
tegies to manage breathlessness. Doctors prescribed
inhalers but patients felt they had not explained how to
use them. Patients said they were useless.
‘I was taking that [inhaler] on the way, [...] and I was
stopping in the street taking that and it never done a thing.
I was breathing in for dear life but it wasn’t helping. [...] I
think that if that don’t work it makes the panic worse,
you’re in a state because you’ve got nothing else to take.’
One patient discovered that his breathing improved
when taking the morphine tablets which he had been pre-
scribed for pain. One patient received oxygen at home.
Self-management consisted of pacing and goal setting, dis-
traction strategies, and one patient always carried a card-
board bag.
Treatment/coping with cancer
Contact with health professionals revolved around tests,
and treatment decisions. When ambivalent results came
back they had the tests repeated to be certain about
whether the symptoms were due to cancer. This was a
stressful time for patients as it involved collaboration with
painful procedures and uncertainty. Patients underwent
surgery with the expectation for cure. Those who could
not be operated went through treatment in the hope to
get cured.
Psychological and spiritual coping mechanisms were
most often mentioned to cope with a poor prognosis.
Where this was too difficult to face, denial, humour,
showing strength, spirituality, and maintaining normality
Table 2 Patient details
Types of
participants
Recruitment
setting
Patients
interviewed
Age
patient
Gender
patient
Number and relation
of patients’ carers
Patients with cancer Outpatient clinic 10 Range: 52-84
Median: 65
5 women
5 men
3 spouses
1 daughter
Patients with COPD Outpatient clinic,
service users meetings,
and community
18 Range: 52-78
Median: 69
9 women
5 men
6 spouses
1 daughter
1 sister
Patients with
cardiac failure
Outpatient clinic 10 Range: 61-80
Median: 69
3 women
7 men
3 spouses
MND patients Outpatient clinic 10 Range: 24-77
Median: 42
1 woman
9 men
8 spouses
1 mother
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view to the next doctor’s appointment. One person
wanted to put the experience behind him after having
had a successful operation.
Consequences
Patients mentioned a variety of consequences of breath-
lessness as part of a cancer diagnosis. They felt guilty
for unhealthy lifestyles and blamed themselves for this.
They put their trust in medicine and they hoped for
cure through surgery.
‘I’d hope to have a lung transplant’
Those who had been told they could not have an
operation hoped that treatment would give them a bit
longer to live. At the same ti m et h e yw e r ea w a r ea b o u t
the progressiveness of their condition and they
expressed concerns about the future. They felt a dimin-
ishing quality of life due to worsening symptoms. They
were worried about losing their independence and
becoming a burden to their family.
COPD
The nature of breathlessness
In the beginning breathlessness showed itself as hardly
noticeable and it developed gradually. Patients easily
adapted to its restrictions as they accepted them silently
in everyday routines and conveniently explained them
away.
“...It (breathlessness) is over time slowing down every-
thing, and it wasn’t until my daughter said: ‘You’re get-
ting so slow mum you’re like an old lady.’ [...] I suppose
that was when I became aware that it was having an
effect on my everyday life.”
Patients spoke about breathlessness in terms of the
feelings associated with bad episodes: distress, anxiety,
panic and fear of dying. They also told as frequently
about the disability it caused, inhibiting every move-
ment. Eleven of the 18 patients evaluated it as their
worst symptom.
Label
Patients only consulted health professionals after having
lived for long periods with breathlessness. When they
were confronted with a crisis, they were alarmed and
they sought medical help. COPD derived its meaning
from other diseases. Those with a smoking history
feared to receive the news they had cancer.
“I’ve been to the doctors and they’ve told me I’ve got
COPD what is it? Now the doctor hasn’t even explained
what those 4 letters mean and the worst thing about it
is, it starts off with C, and first thing you think: Oh have
I got cancer but this is the thing that is wrong its not a
well known disease yet its one of the greatest killers.”
Instead of a definite diagnosis, patients received differ-
ent labels: bronchitis, COPD, asthma, emphysema. The
acronym of COPD starts with “chronic”, implying a
long-term and relatively manageable condition.
Timeline
Over time, sufferers found out for themselves what
breathlessness means: daily troubles with breathing,
impaired mobility, anxiety restricting them to home,
growing dependence. Patients started a quest for effec-
tive treatment once they realised the full extent of the
symptoms. However, this proved to deliver little in
terms of relief. Over time they built up knowledge,
through personal experience, often without much
expert advice. In the advanced stages of illness they re-
evaluated the diagnosis and identified issues which had
been left unaddressed. Patients found that full disclo-
sure of the nature and course of breathlessness was
crucial for its management.
“At the time if I can remember rightly we weren’t
really told that [...] it would gradually get worse. [...] We
were just told this is what you’ve got, get on with it.”
Cause
All 18 patients with COPD mentioned external causes
for their diagnosis, one person added an internal cause.
All patients attributed breathlessness to a lifetime of
smoking. They mentioned its detrimental effects:
“I am poisoned.”
“...it’s a terrible condition but then it’s self-inflicted
with the cigarettes”
Patients felt guilty about breathlessness; they felt
responsible for having it brought onto themselves.
Treatment/coping with breathlessness
All patients had experience with inhalers and steroids,
but inhalers offered minimal relief, and steroids caused
side effects. Five patients relied on oxygen at home. Six
had a nebuliser, two had purchased one on their own.
They were unanimous that it helped their breathing and
calmed them down.
Eight patients said they had never had any advice on
how to manage their breathlessness.
“Id o n ’tk n o ww h a tt od o [ . . . ]y o uc a n ’tr u nt ot h ed o c -
tor every 5 minutes, you can’t run to casualty, you need
to know how to deal with things yourself, [...] at least be
discussing them...”
In the absence of professional advice one patient men-
tioned simple strategies: steam baths, a fan, open
windows.
Five patients went to PR classes. They learned the
necessary skills and behaviours to self-manage and this
gave them an acceptable quality of life.
Treatment/coping with COPD
Only the patients who received PR said they cope rea-
sonably well. Those who did not said that breathlessness
inhibited every movement which led patients to reduce
their activities even more, to the essentials. Gradual
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‘magic pill’ for their suffering.
Consequences
Disability was mentioned most frequently. They were
often restricted to the home leading to social isolation.
Disability caused financial hardship as they lost their
jobs, partners took on the role of carer over time. They
spoke of having problems with access to care. Stigma
added to patients suffering. Patients were not prepared
to face the future and expressed only to be able to cope
with one day at a time.
Heart failure
The nature of breathlessness
Patients with heart failure could sometimes not trace the
first experiences of breathlessness back to a specific
moment. This was due to the slow process of how it
develops over time. Patients adapted their activities to
what the breathlessness allowed them to do and they got
used to it as a part of daily life.
“...but the breathlessness as I have now has been creep-
ing on quite insidiously so it’s hard to define.”
They described the symptom mostly in terms of the
limitations it imposed to their daily functioning, and less
so in evaluative or emotional terms.
Label
Patients used the terms heart failure and heart attack to
refer to what was wrong with their health. They also used
more specific labels and descriptions, and spoke of cardi-
omyopathy, angina, the ejection fraction being lower
than normal, hardening of the heart walls, arrythmia etc.,
using the terms with which their physicians had commu-
nicated the diagnosis. These were immediate diagnoses,
except for one person where cancer was suspected. Heart
failure carried meaning, patients recognised the serious-
ness of their condition.
Timeline
After the diagnosis all patients underwent surgery,
except one person whose doctor told him that there was
only 30% that the operation would be successful. Sur-
gery was life-saving.
“...(the doctor said): we’ll have you in and I say: ‘Oh
b u tw h a ti fId o n ’t have the operation?’ He said well:
‘Your next heart attack ‘ll kill ya.”
When time had passed after the operation, patients
realised that surgery did not bring them back to their
old healthy selves. They experienced several symptoms
they actively had to manage: pain, the build up of fluid,
tiredness, breathlessness.
Cause
All patients attributed their heart problems to internal
causes, due to a mechanical fault in their body.
“I think it’s because the heart ‘s not pumping as well as
it should be.”
Two also identified external causes, one to smoking
and one to an injury at work.
Treatment/coping with breathlessness
All patients had experience with inhalers but found them
of limited use. Only one used a nebuliser and oxygen
which made him feel safe. Two patients went to PR
classes. Except for those two, all others said that they had
never received advice on how to cope with breathlessness.
Patients said that they did not always report breathless-
ness, they did not see that as the role of the clinic; health
professionals never asked about breathlessness, and one
patient was concerned she would give the impression of
being a hypochondriac.
In the absence of professional advice they applied
avoidance, planning and pacing strategies.
Treatment/coping with heart failure
All patients except one had accepted surgery despite the
information they received about the risks involved. They
talked about the hope it had given them initially, how-
ever, after the operation they had slowly realised that it
had not brought them the improvements they had
expected.
Carer: You sort of thought that was [...] the major
thing the operation, and everything was gonna be alright
after that.
Patient:... and it’s a bit of an awakening although we
were told beforehand. I think you tend to put too much
hope.
They told about symptoms becoming worse over time
and they were prescribed hefty pill regimes needing
active management. Some of the medication caused
heavy side-effects or created other symptoms and
patients balanced the benefits versus their actual quality
of life.
Consequences
Disability was mentioned most frequently as a conse-
quence of heart failure.
“... sometimes it depresses me coz you feel [...] useless,
incompetent, you can’t do a simple task, like I try to put
me socks on and I’m struggling and I might get one on
with a bit of luck and I go to get the other one and I
have to give up and I’m upset.”
They spoke of problems with access to care, and to
the slow response from social services. They complained
about little coordination among health professionals in
the community.
Breathlessness was a contributing factor to the nega-
tive effects of other symptoms. Stigma was mentioned
three times by patients.
Patients were worried about the future, they feared
they would experience another heart attack and die.
Daily life with troubling symptoms and restricted mobi-
lity made them think about life before death and they
expressed uncertainty if life would be worthwhile.
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beta-blockers. Erm that will protect you but make you a
vegetable at the same time, erm ... I’m not interested in
being a vegetable...”
MND
The nature of breathlessness
Patients traced back first breathing difficulties when they,
or a carer noticed a different breathing pattern had devel-
oped. This coincided with other symptoms such as dis-
turbed sleep, nightmares, hallucinations, headaches etc.
They learned that these symptoms were related to their
breathing when seeking help at the hospital.
Patients described the sudden onset of breathlessness.
All spoke about the anxiety and fear it went together
with. They said it had worsened their disability, limiting
them even more. Breathlessness made patients realise
that the illness affects mechanisms essential for living.
Only two patients evaluated breathlessness as the
worst symptom. Other symptoms overshadowed breath-
lessness such as loss of speech.
One patient made a distinction between daily and cri-
tical breathlessness. When experiencing critical breath-
lessness he described not being able to breathe at all
and this went together with panic, it was a matter of life
and death, requiring fast action.
Label
Patients had experienced a long search before they
received a diagnosis of MND. As this is a rare condition,
health practitioners outside neurology were not always
familiar with the symptoms. A man who experienced
speech difficulties was first referred to the dentist,
another person whose foot dropped was sent to the rheu-
matologist. Several months, to a year passed between first
symptoms and diagnosis. Two of the 10 patients found
they had MND through self-diagnosis. Seven people
learned about the condition when they received their
diagnosis. When they were asked about the effect of
knowing they had MND they used words, phrases, that
showed the serious, drastic impact of this news: ‘deva-
stated’, ‘a bolt out of the blue’, ‘you turn a corner’, ‘death
sentence’.
Timeline
The main message of the diagnosis in this condition was
the prognosis, which is uncertain and short. This drasti-
cally changed outlook to the future was managed in dif-
ferent ways. When still little affected by the illness
people went on holidays, and delayed or restricted
disclosure.
People needed time to come to terms with symptoms
and future. They became aware of this in a step-by-step
manner, each time when they were affected by another
loss. Their strategy was to live in the present. They
acknowledged their prospect of worsening symptoms.
One person said: ‘this doesn’tt a k ea n yp r i s o n e r s ’ when
comparing MND to cancer, another life-limiting illness
where patients might be released by cure.
Cause
All MND patients said that the cause of the illness was
unknown, even to medicine. Therefore it overcame peo-
ple, which happened beyond control.
“... er motor neurones disease it’sn o tc a u s e db ya n y -
thing that we know of they don’t know, you just get it...”
Treatment/coping with breathlessness
Nine patients used non-invasive intermittent positive
pressure ventilation (NIPPY) and for one it was consid-
ered. Three patients reported difficulties using it. For
those who had incorporated it in their daily routines it
was the solution for their previous breathing problems.
They were monitored by a respiratory physician at the
hospital and had received advice from physiotherapists.
They used positional and other techniques to relieve
breathing difficulties.
Two people received medication, in the case of dis-
tressing breathlessness the person was given morphine.
In the other case the carer was advised to give Loraze-
pam to the patient when critical breathlessness set in.
The respiratory physician at the hospital had sug-
g e s t e dat r a c h e o s t o m yt oo n ep e r s o nw h i c hh ef o u n d
very upsetting.
Treatment/coping with MND
Patients said there was a team of specialists they could
always rely on. They were grateful for their help, how-
ever in times they were not needed they appreciated to
be left alone. They tried to maintain normality in their
lives. Also technology was accepted both with reluctance
and appreciation.
O n ep e r s o nh a du n d e r g o n ea n t i c i p a t o r ys u r g e r y .H e
expressed the difficulty to come to terms with the gas-
trostomy, another loss, which was not even directly
brought about by the illness.
Six patients mentioned they took Riluzole, a drug
aimed to slow down the progression of the illness.
They resorted in the absence of hope for a cure to
psychological and spiritual coping mechanisms.
“There’s nothing worse that can happen now...”
Consequences
All patients spoke about the effects of progressing dis-
ability: loss of work, independence, future, relationships,
sexuality, one’s home.
“MND turned life totally upside down”
Some patients mentioned also gains because of the ill-
ness, which were closer relationships with families and a
belief in the kindness of mankind.
All patients were concerned about their illness affect-
ing their family, relating to carers in their caregiving
role or what would happen to their loved ones after
their death. Patients prepared for death, if not through
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after their death.
Three patients experienced stigma as part of MND.
Discussion
This study found differences in how patients experience
breathlessness across different conditions, as a physical
sensation. These patterns, characteristic for different ill-
nesses are further shaped by their experiences with the
health care context and social environment [17-19]. This
has an effect on how patients make sense of their symp-
toms, whether these are recognised, when these trigger a
response in terms of health seeking, who is consulted,
and what treatment is considered appropriate. The label-
ling of the condition responsible for one’ss y m p t o m s
frames the perception of the illness [20,21]. There
appeared systematic differences in the type of causes
patients ascribed to their illness across the four condi-
tions. External causes were linked to the idea that these
fell within their control and responsibility. The experi-
ence of breathlessness is dependent on the distinct treat-
ment approaches prevailing in medical specialist cultures.
In cancer, there was little attention to breathlessness
within a test and cure-oriented approach. COPD patients
initially experienced breathlessness as a symptom of a
chronic illness. Responses from services disaffirmed
patients’ experience of breathlessness, discouraging them
from presenting their problems [8]. Patients with heart
failure described breathlessness as a contributing factor
to the negative effects of other symptoms. Breathlessness
in MND appeared as a constant reminder that the illness
was a dangerous threat to patients’ lives, undoing their
attempts to maintain normality. In the face of these chal-
lenges they resorted to psychological and spiritual coping
strategies.
Although we identified rather homogenous experiences
in separate diseases, unique experiences within these dis-
e a s e sn e e dt ob er e c o g n i s e d .T h ep a t i e n t si nt h i ss t u d y
belonged to separate conditions. In reality more patients
have multiple conditions and complex patterns of symp-
toms. However, the EM and symptom schema provided
systematic frameworks for the comparison across condi-
tions and the approach of the constant comparative
method also provided set procedures for the analysis
while still respecting the evolving, inductive nature of
enquiry needed for these qualitative data.
There are only a handful of studies that have compared
the needs of patients with an advanced condition where
breathlessness is a major symptom. They have all focused
on cancer and COPD [22-27], except for Bekelman
et al. [28] who compared cancer and heart failure. The
studies found that patients had similar symptom burdens,
and equivalent needs for palliative care, while those
patients with other than cancer diagnoses had problems
with access and utilisation of care. A few studies that
took breathlessness as the unit of comparison in different
conditions showed differences in the pattern of breath-
lessness [29,30], which is related to differences in disease
progression [10,31]. Our study is the first one to compare
breathlessness across multiple conditions. It adds to the
insights of previous studies by showing how breathless-
ness affects patients in different ways across different
conditions. Through a broad approach we obtained a
contextualised view of how the symptom is experienced
within the constraints the illness imposes on the body
a n dt h er e s p o n s e st h i se v o k e sf r o mh e a l t hc a r ea n d
society. In this way it was possible to include all aspects
that account for ‘total breathlessness’ [32].
The obvious conclusion on the basis of our findings
that breathlessness is experienced differently in different
conditions would be to refine its management and tailor
interventions to specific patient groups. However, we
found that the problems were often a result of the dis-
ease-specific services and treatments that patients with
different diagnoses receive. Examples are the barriers to
access of services for patients with COPD and heart fail-
ure, or the primacy given to disease status in the case of
cancer influencing the perception and management of
symptoms. Such specialist approaches are too narrow in
focus for the relief of a complex symptom as breathless-
ness as they pay insufficient attention to what this
symptom means to the daily life of those affected [33].
Palliative care is equipped to address the different
dimensions -the physical, psychological and spiritual- of
breathlessness with its holistic approach. This enables
the recognition of the distress and disability it causes
across all the conditions, and ensures equitable distribu-
tion of resources. At the same time its focus on the
individual can build on the expertise developed in differ-
ent conditions. This study started a much needed evi-
dence-base of the patient’s experience of breathlessness
across different life-limiting illnesses. This symptom
crosses disease, medical and body-mind boundaries [34].
It needs all appropriate therapeutic options from across
the disease spectrum, collaborative efforts from health,
social care professionals, patients and caregivers, and
therapies that acknowledge the dynamic interrelation of
the body, mind and spirit.
Such integrated models of care are needed for complex
problems in chronic, life-limiting illness [35]. Interven-
tions that build on broader conceptions of the symptom
such as the work by Corner [36,37], and the Breathless-
ness Intervention Service [38] need further testing with
breathless patients from several patient groups.
Limitations of the study
The findings from this study can not be generalised to
populations. This study rather aimed to tease out
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lessness across the conditions focused on, however the
findings permit the type of generalisations that can be
made from and about cases (idiographic generalisation).
Conclusion
This is the first study that compared breathlessness in
four conditions, to find that the experience of the symp-
tom differs across these separate conditions. These find-
ings have important implications for practice as the
problems identified were often a result of the disease-
specific services and treatments that patients with differ-
ent diagnoses receive. They show that integrated models
of care based on collaborative efforts among all those
involved and a broad conception of the symptom are
needed.
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